UNSPSC 51282134: Oximonam sodium

This classification denotes a beta-lactam antibiotic C12H14N5O6S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G274R51QFV, chemically known as acetic acid, 2-(((2s,3s)-3-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-2-methyl-4-oxo-1-azetidinyl)oxy)-, sodium salt (1:1), but more generally known as oximonam sodium, which bears US NIH Compound Identifier 23663948. Most nations, for tariff and trade purposes, schedule oximonam sodium under HS 29419000 and SITC 54139.

As of Q4 2014, OXIMONAM SODIUM remains US FDA's Preferred Term for this commodity. Oximonam sodium bears US NLM identifiers UMLS ID C1882241 and NCI Concept Code C66267. SMILES: C[C@H]1[C@@H](C(=O)N1OCC(=O)[O-])NC(=O)/C(=N\OC)/C2CSC(N2)N.[NA+].

UNSPSC 51282134 Oximonam sodium is a Commodity code that encompasses pharmaceutical products and related health supplies procured by state and local governments for community health, emergency response, and pharmacy benefit programs. The recent opportunities tagged to this code show state and local buyers acquiring naloxone, safe drug deactivation systems, medical and first aid supplies for fire and rescue operations, and generic pharmaceuticals through cooperative purchasing vehicles. These solicitations span county health departments, municipal fire rescue divisions, state health and human services agencies, and multistate cooperative purchasing alliances—indicating a diverse issuer base that includes single-jurisdiction health and emergency-response buyers as well as statewide and regional procurement consortia.

Recent activity clusters in Florida and Minnesota, with additional engagement in Texas and participating states within cooperative purchasing agreements. Seminole County, Florida released IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026; the City of Tampa issued ITB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for its Fire Department Rescue Division at an estimated contract value of $700,000, with a Small Local Business Enterprise set-aside and 5 percent bid discount. The Minnesota Department of Administration, on behalf of MMCAP, posted RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with distribution through three authorized wholesalers and a response deadline of March 26, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs, signaling upstream procurement intent in that state.